<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) are rare in children, representing 3% or less of <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C0376544" disease_type="Neoplastic Process" abbrv="">hematopoietic malignancies</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Cytogenetic abnormalities, such as -7/7q-, +8, and +21 have been reported in 55-80% of children with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Cytogenetic studies have an important impact on diagnosis, treatment selection, and monitoring therapeutic protocols when combined with morphologic data </plain></SENT>
<SENT sid="3" pm="."><plain>We report on a pediatric case of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with the presence of the rare clonal abnormality del(13)(q14q22) which underwent a <z:e sem="disease" ids="C1608408" disease_type="Neoplastic Process" abbrv="">malignant transformation</z:e> to <z:hpo ids='HP_0001909'>leukemia</z:hpo> and ran a very poor clinical course </plain></SENT>
</text></document>